first trust select dsip fact sheet Common Federation Requirements DSAC Fact Sheet — FBI

CJC-1295/Ipamorelin or tesamorelin can provide additional GH-mediated lean mass support during weight loss phases

The first few hours Mild soreness, slight redness, or a faint bruise at the injection site are all common and expected

A break of 4-8 weeks is recommended before starting a new cycle

Individuals using GLP-1 medications may experience: Reduced caloric and protein intake Early satiety or nausea Gastrointestinal changes that affect absorption Increased fatigue during metabolic adjustment Because B-complex vitamins support energy metabolism, neurological pathways, and gastrointestinal integrity, supportive supplementation may be considered when intake is reduced or oral tolerance is limited